Literature DB >> 2189896

Reversal of beta-cell suppression in vitro in pancreatic islets isolated from nonobese diabetic mice during the phase preceding insulin-dependent diabetes mellitus.

E Strandell1, D L Eizirik, S Sandler.   

Abstract

Insulin-dependent diabetes mellitus (IDDM) is characterized by a progressive autoimmune destruction of the pancreatic beta-cells. One of the best-suited animal models for IDDM is the nonobese diabetic (NOD) mouse. In this investigation pancreatic islets were isolated from female NOD mice aged 5-7, 8-11, and 12-13 wk and examined immediately (day 0) or after 7 d of culture (day 7). The mice showed a progressive disturbance in glucose tolerance with age, and a correspondingly increased frequency of pancreatic insulitis. Islets isolated from the oldest mice often contained inflammatory cells on day 0, which resulted in an elevated islet DNA content. During culture these islets became depleted of infiltrating cells and the DNA content of the islets decreased on day 7. Islets of the eldest mice failed to respond with insulin secretion to high glucose, whereas a response was observed in the other groups. After culture all groups of islets showed a markedly improved insulin secretion. Islets from the 12-13-wk-old mice displayed a lower glucose oxidation rate at 16.7 mM glucose on day 0 compared with day 7. Islet (pro)insulin and total protein biosynthesis was essentially unaffected. In conclusion, islets obtained from 12-13-wk-old NOD mice exhibit an impaired glucose metabolism, which may explain the suppressed insulin secretion observed immediately after isolation. This inhibition of beta-cell function can be reversed in vitro. Thus, there may be a stage during development of IDDM when beta-cell destruction can be counteracted and beta-cell function restored, provided the immune aggression is arrested.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2189896      PMCID: PMC296662          DOI: 10.1172/JCI114657

Source DB:  PubMed          Journal:  J Clin Invest        ISSN: 0021-9738            Impact factor:   14.808


  51 in total

1.  Determination of total serum insulin (IRI) in insulin-treated diabetic patients.

Authors:  L G Heding
Journal:  Diabetologia       Date:  1972-08       Impact factor: 10.122

2.  Viability tests of cryopreserved endocrine pancreatic cells.

Authors:  A Andersson; S Sandler
Journal:  Cryobiology       Date:  1983-04       Impact factor: 2.487

3.  Long-term exposure of isolated pancreatic islets to mannoheptulose: evidence for insulin degradation in the beta cell.

Authors:  P A Halban; C B Wollheim; B Blondel; A E Renold
Journal:  Biochem Pharmacol       Date:  1980-10-01       Impact factor: 5.858

Review 4.  Interleukin-2 dependent culture of cytolytic T cell lines.

Authors:  S Gillis; J Watson
Journal:  Immunol Rev       Date:  1981       Impact factor: 12.988

5.  Differential sensitivity to beta-cell secretagogues in "early," type I diabetes mellitus.

Authors:  O P Ganda; S Srikanta; S J Brink; M A Morris; R E Gleason; J S Soeldner; G S Eisenbarth
Journal:  Diabetes       Date:  1984-06       Impact factor: 9.461

Review 6.  Insulin release : the fuel concept.

Authors:  W J Malaisse
Journal:  Diabete Metab       Date:  1983-12

7.  Potassium ions and the secretion of insulin by islets of Langerhans incubated in vitro.

Authors:  S L Howell; K W Taylor
Journal:  Biochem J       Date:  1968-06       Impact factor: 3.857

8.  Immunoglobulin from insulin-dependent diabetic children inhibits glucose-induced insulin release.

Authors:  T Kanatsuna; S Baekkeskov; A Lernmark; J Ludvigsson
Journal:  Diabetes       Date:  1983-06       Impact factor: 9.461

9.  Preventive and therapeutic effects of large-dose nicotinamide injections on diabetes associated with insulitis. An observation in nonobese diabetic (NOD) mice.

Authors:  K Yamada; K Nonaka; T Hanafusa; A Miyazaki; H Toyoshima; S Tarui
Journal:  Diabetes       Date:  1982-09       Impact factor: 9.461

10.  The influence of cyclosporin A on the vascular permeability of the pancreatic islets and on diabetes induced by multiple low doses of streptozotocin in the mouse.

Authors:  L Jansson; S Sandler
Journal:  Virchows Arch A Pathol Anat Histopathol       Date:  1988
View more
  23 in total

1.  Immunomodulatory therapy of human type 1 diabetes: lessons from the mouse.

Authors:  J P Palmer
Journal:  J Clin Invest       Date:  2001-07       Impact factor: 14.808

Review 2.  The differentiation of the immune system towards anti-islet autoimmunity. Clinical prospects.

Authors:  C Boitard
Journal:  Diabetologia       Date:  1992-12       Impact factor: 10.122

3.  Prolonged exposure of pancreatic islets isolated from "pre-diabetic" non-obese diabetic mice to a high glucose concentration does not impair beta-cell function.

Authors:  D L Eizirik; E Strandell; S Sandler
Journal:  Diabetologia       Date:  1991-01       Impact factor: 10.122

4.  Questioning four preconceived ideas on immunotherapy of clinical type 1 diabetes: lessons from recent CD3 antibody trials.

Authors:  Lucienne Chatenoud; Jean-François Bach
Journal:  Rev Diabet Stud       Date:  2005-11-10

5.  β cell death and dysfunction during type 1 diabetes development in at-risk individuals.

Authors:  Kevan C Herold; Sahar Usmani-Brown; Tara Ghazi; Jasmin Lebastchi; Craig A Beam; Melena D Bellin; Michel Ledizet; Jay M Sosenko; Jeffrey P Krischer; Jerry P Palmer
Journal:  J Clin Invest       Date:  2015-02-02       Impact factor: 14.808

Review 6.  Immune therapy for type 1 diabetes mellitus-what is unique about anti-CD3 antibodies?

Authors:  Lucienne Chatenoud
Journal:  Nat Rev Endocrinol       Date:  2010-03       Impact factor: 43.330

7.  Contribution of different mechanisms to pancreatic beta-cell hyper-secretion in non-obese diabetic (NOD) mice during pre-diabetes.

Authors:  Kuo Liang; Wen Du; Wenzhen Zhu; Shuang Liu; Yeqing Cui; Haichen Sun; Bin Luo; Yanhong Xue; Lu Yang; Liangyi Chen; Fei Li
Journal:  J Biol Chem       Date:  2011-09-13       Impact factor: 5.157

Review 8.  The role of inflammation in insulitis and beta-cell loss in type 1 diabetes.

Authors:  Décio L Eizirik; Maikel L Colli; Fernanda Ortis
Journal:  Nat Rev Endocrinol       Date:  2009-04       Impact factor: 43.330

9.  Deoxyhypusine synthase promotes differentiation and proliferation of T helper type 1 (Th1) cells in autoimmune diabetes.

Authors:  Stephanie C Colvin; Bernhard Maier; David L Morris; Sarah A Tersey; Raghavendra G Mirmira
Journal:  J Biol Chem       Date:  2013-11-06       Impact factor: 5.157

10.  Human autoantibodies react with glutamic acid decarboxylase antigen in human and rat but not in mouse pancreatic islets.

Authors:  L A Velloso; O Kämpe; D L Eizirik; A Hallberg; A Andersson; F A Karlsson
Journal:  Diabetologia       Date:  1993-01       Impact factor: 10.122

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.